資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://nccur.lib.nccu.edu.tw/handle/140.119/157721
|
| 題名: | 以動態能力的觀點探討外商藥廠的永續管理－以A公司為例
Exploring the Sustainability Management of Multinational Pharmaceutical Companies from the Perspective of Dynamic Capabilities: A Case Study of Company A |
| 作者: | 林勤文
Lin, Chin-Wen |
| 貢獻者: | 吳豐祥
Wu, Feng-Shang
林勤文
Lin, Chin-Wen |
| 關鍵詞: | 動態能力
永續管理
外商藥廠
跨國企業
Dynamic Capability
Sustainability Management
Foreign Pharmaceutical Companies
Multinational Enterprises |
| 日期: | 2025 |
| 上傳時間: | 2025-07-01 14:32:24 (UTC+8) |
| 摘要: | 隨著全球永續發展議題日益受到重視，外商藥廠面臨來自國際法規、社會
期待與產業競爭的多重壓力，促使企業須在穩健經營與永續創新間尋求動態平衡。在生技醫藥產業中，企業不僅需因應各國政府對環境、社會與治理標準的規範，亦需回應醫療專業倫理與地方社會之期待。永續管理因此成為企業長期發展策略中不可或缺的一環。
然而，永續管理不僅涉及策略規劃與資源投入，更需結合母公司與子公司
之間的協作機制，建構因應環境變遷的動態調適能力。本研究以Teece (2007; 2018a)所提出之動態能力架構為理論主軸，結合永續管理架構與跨國企業網絡觀點，探討外商藥廠子公司如何透過動態能力的建構來推動永續管理，並進一步分析子公司與總部之間如何協調資源與知識以實現永續價值。
本研究採用質性研究法，以外商藥廠子公司個案公司A為研究對象，透過
深度訪談，佐以次級資料的蒐集分析，歸納出該企業的永續管理推動過程中各構面之實務作為與內部互動邏輯。所得到的主要結論如下：
一、外商藥廠子公司在推動永續管理過程的感知上，會由被動轉為主動，並會結合母公司全球策略、利益相關者意見，以及子公司在地知識，建構雙向
資訊流動機制，以強化永續感知與策略連結。
二、外商藥廠子公司在推動永續管理過程的機會捕捉上，會結合全球統一策略框架、在地需求與組織資源，以建構動態且具滾動調整能力的永續目標與
策略捕捉能力。
三、外商藥廠子公司在推動永續管理過程的策略制度上，會透過總部資源支
持、高階主管引導推動、組織學習機制與結構調整等，來強化策略捕捉過
程中的組織吸收與學習能力，以落實策略與持續優化。
四、外商藥廠子公司在推動永續管理過程的轉換上，會透過資源再配置與內部文化建構等作法，來強化其轉換能力，並促進永續策略從規劃到執行的有
效轉化。
五、外商藥廠子公司在推動永續管理的過程中，會透過制度化的評估與回饋機制，來強化其永續管理的績效與調整，並透過經濟、社會與環境等三層面
多元價值創造，來展現出其永續導向的競爭優勢。
最後，本論文並闡述本研究在學術上的貢獻，以及實務上與後續研究上的
建議。
As global attention to sustainable development continues to grow, foreign pharmaceutical companies are facing mounting pressures from international regulations, societal expectations, and industry competition. These challenges compel enterprises to strike a dynamic balance between stable operations and sustainable innovation. In the biotechnology and pharmaceutical industry, companies must not only comply with diverse ESG standards set by various governments but also respond to medical ethics and local community expectations. Sustainability management has therefore become an essential part of long-term corporate strategy.
However, effective sustainability management involves more than strategic planning and resource allocation. It also requires collaborative mechanisms between headquarters and subsidiaries to build dynamic capabilities for adapting to
environmental changes. Drawing on Teece’s (2007; 2018a) dynamic capabilities framework as its theoretical foundation, this study integrates sustainability management principles and multinational enterprise network perspectives to explore how foreign pharmaceutical firms develop dynamic capabilities to implement sustainability strategies. It further examines how headquarters and subsidiaries coordinate resources and knowledge to create sustainable value.
This research adopts a qualitative case study approach, using Company A as the focal case. Data were collected through in-depth interviews and secondary document analysis to identify practical actions and internal interaction logic across various stages of the sustainability management process. Key research findings include:
1. Subsidiaries of foreign pharmaceutical companies are transitioning from passive execution to proactive sensing, aligning global strategies from headquarters with local knowledge from subsidiaries, and establishing bidirectional information flow mechanisms to enhance sustainability awareness and strategic alignment.
2. Subsidiaries of foreign pharmaceutical companies integrate global strategic frameworks, local demands, organizational resources, and stakeholder perspectives to formulate flexible and adaptive sustainability goals and
strategies.
3. Through headquarters resource support, leadership engagement, and organizational learning mechanisms, subsidiaries of foreign pharmaceutical companies enhance absorptive and learning capabilities during the strategy
formulation phase to ensure execution and continuous optimization.
4. Structural adjustments, resource reallocation, and cultural embedding of
subsidiaries of a foreign pharmaceutical companies strengthen transformation capabilities, enabling effective implementation of sustainability strategies.
5. Institutionalized evaluation and feedback mechanisms of subsidiaries of a foreign pharmaceutical companies improve sustainability performance and enable ongoing adjustments, thereby generating multi-dimensional value across economic, social, and environmental dimensions and reinforcing sustainability oriented competitive advantages.
The end of the thesis presents academic contributions, practical implications, and recommendations for future research. |
| 參考文獻: | Alavi, M., & Leidner, D. E. (2001). Review: Knowledge management and knowledge management systems: Conceptual foundations and research issues. MIS Quarterly, 25(1), 107–136. https://doi.org/10.2307/3250961
AstraZeneca. (2024). Sustainability report 2023. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/Sustainability-Report-2023.pdf
AstraZeneca. (2024). AZ impact publication 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2024/pdf/AZImpact-Publication-2024.pdf
AstraZeneca. (2025). Sustainability data annex 2024. Retrieved April 1, 2025, from https://www.astrazeneca.com/content/dam/az/Sustainability/2025/pdf/Sustainability-Data-Annex-2024.pdf
Barney, J. (1991). Firm resources and sustained competitive advantage. Journal of Management, 17(1), 99–120. https://doi.org/10.1177/014920639101700108
Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. Boston, MA: Harvard Business School Press.
Baumgartner, R. J., & Rauter, R. (2016). Strategic perspectives of corporate sustainability management to develop a sustainable organization. Journal of Cleaner Production, 140(2), 81–92. https://doi.org/10.1016/j.jclepro.2016.04.146
Bieker, T. (2003). Sustainability management with the Balanced Scorecard [Working paper]. Institute for Economy and the Environment, University of St. Gallen.
Birkinshaw, J., & Hood, N. (1998). Multinational subsidiary evolution: Capability and charter change in foreign-owned subsidiary companies. Academy of Management Review, 23(4), 773–795.
BlackRock. (2020). A fundamental reshaping of finance. Retrieved March 9, 2025, from https://www.blackrock.com
Bowen, H. R. (1953). Social responsibilities of the businessman. Harper & Row.
Chittoor, R., & Ray, S. (2007). Internationalization paths of Indian pharmaceutical firms—A strategic group analysis. Journal of International Management, 13(3), 338–355.
Davenport, T. H. (1998). Working knowledge: How organizations manage what they know. Retrieved January 19, 2025, from https://doi.org/10.1145/348772.348775
DiMaggio, P. J., & Powell, W. W. (1983). The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American
Sociological Review, 48(2), 147–160.
Dunlap-Hinkler, D., Mudambi, R., & Kotabe, M. (2010). A story of breakthrough versus incremental innovation: Corporate entrepreneurship in the global pharmaceutical industry. Strategic Entrepreneurship Journal, 5(2), 106–127.
Dyllick, T., & Hockerts, K. (2002). Beyond the business case for corporate sustainability. Business Strategy and the Environment, 11(2), 130–141.
Eisenhardt, K. M., & Martin, J. A. (2000). Dynamic capabilities: What are they?
Strategic Management Journal, 21(10–11), 1105–1121. https://doi.org/10.1002/1097-0266(200010/11)21:10/11<1105::AIDSMJ133>3.0.CO;2-E
Elkington, J. (1997). Cannibals with forks: The triple bottom line of 21st-century business. Capstone.
European Commission. (2019). The European Green Deal. Retrieved March 10, 2025, from https://ec.europa.eu/green-deal
Figge, F., Hahn, T., Schaltegger, S., & Wagner, M. (2002). The sustainability balanced scorecard – Linking sustainability management to business strategy. Business
Strategy and the Environment, 11(5), 269–284. https://doi.org/10.1002/bse.339
Foss, N. J., & Pedersen, T. (2004). Organizing knowledge processes in the multinational corporation: An introduction. Journal of International Business Studies, 35(5), 340–349.
Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman.
Friede, G., Busch, T., & Bassen, A. (2015). ESG and financial performance: Aggregated evidence from more than 2000 empirical studies. Journal of Sustainable Finance & Investment, 5(4), 210–233.
Gassmann, O., Reepmeyer, G., & von Zedtwitz, M. (2008). Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry.
Springer Science & Business Media. GlobalData. (2024). The future of pharma: Insight and analysis.
Hart, S. L., & Milstein, M. B. (2003). Creating sustainable value. Academy of Management Executive, 17(2), 56–69.
Helfat, C. E., & Martin, J. A. (2015). Dynamic managerial capabilities: Review and assessment of managerial impact on strategic change. Journal of Management,
41(5), 1281–1312. https://doi.org/10.1177/0149206314561301
Helfat, C. E., & Peteraf, M. A. (2018). Managerial cognitive capabilities and the microfoundations of dynamic capabilities. Strategic Management Journal, 36(6),
831–850. https://doi.org/10.1002/smj.2247
Hossain, M. U., Ng, S. T., & Antwi-Afari, M. F. (2020). A review of the sustainable building life cycle assessment research trend: Current status and future needs.
Sustainability, 12(18), 7705. https://doi.org/10.3390/su12187705
Intergovernmental Panel on Climate Change (IPCC). (2018). Global warming of 1.5°C: Special report. Retrieved March 9, 2025, from https://www.ipcc.ch
IQVIA Institute for Human Data Science. (2024). The global use of medicines 2024: Outlook to 2028.
Manolopoulos, D., Söderquist, K. E., & Pearce, R. (2011). Coordinating decentralized research and development laboratories: A survey analysis. Journal of International Management, 17(2), 114–129.
Mäkelä, K., & Brewster, C. (2009). Interunit interaction contexts, interpersonal social capital, and the differing levels of knowledge sharing. Human Resource Management, 48(4), 591–613. https://doi.org/10.1002/hrm.20300
Malerba, F., & Orsenigo, L. (2015). The evolution of the pharmaceutical industry. Business History, 57(5), 664–687.
Microsoft. (2020). Microsoft will be carbon negative by 2030. Retrieved March 2, 2025, from https://blogs.microsoft.com
Meyer, K. E., & Su, Y. S. (2015). Integration and responsiveness in subsidiaries in emerging economies. Journal of World Business, 50(1), 149–158.
Mudambi, R., & Swift, T. (2011). Leveraging knowledge and competencies across space: The next frontier in international business. Journal of International Management, 17(3), 186–189.
Nawaz, W., & Koç, M. (2018). Development of a systematic framework for sustainability management of organizations. Journal of Cleaner Production, 171, 1255–1274. https://doi.org/10.1016/j.jclepro.2017.10.011
Pisano, G. P. (2006). Science business: The promise, the reality, and the future of biotech. Harvard Business Press.
Porter, M. E., & Kramer, M. R. (2011). Creating shared value. Harvard Business Review, 89(1/2), 62–77.
Principles for Responsible Investment (PRI). (2006). The Principles for Responsible Investment. Retrieved March 2, 2025, from https://www.unpri.org
Sala, S., Ciuffo, B., & Nijkamp, P. (2015). A systemic framework for sustainability assessment. Ecological Economics, 119, 314–325.
Schweizer, L. (2005). Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach. Academy of Management Journal, 48(6), 1051–1074.
Searcy, C. (2009). The role of sustainable development indicators in corporate decision-making. International Journal of Sustainable Development & World Ecology, 16(2), 89–98. Retrieved March 3, 2025, from https://citeseerx.ist.psu.edu/document? repid=rep1&type=pdf&doi=14e429573f02177da59e7150bf72a663ea2a2781
Sheldon, O. (1923). The philosophy of management. Pitman.
Starik, M., & Kanashiro, P. (2013). Toward a theory of sustainability management: Uncovering and integrating the nearly obvious. Organization & Environment, 26(1), 7–30. https://doi.org/10.1177/1086026612474958
Teece, D. J. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)10970266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
Teece, D. J. (2007). Explicating dynamic capabilities: The nature and microfoundations of (sustainable) enterprise performance. Strategic Management Journal, 28(13), 1319–1350. https://doi.org/10.1002/smj.640
Teece, D. J. (2018a). Business models and dynamic capabilities. Long Range Planning, 51(1), 40–49. https://doi.org/10.1016/j.lrp.2017.06.007
Teece, D. J. (2018b). Dynamic capabilities as (workable) management systems theory. Journal of Management & Organization, 24(3), 359–368. https://doi.org/10.1017/jmo.2017.75
Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533. https://doi.org/10.1002/(SICI)1097-0266(199708)18:7<509::AIDSMJ882>3.0.CO;2-Z
United Nations. (2005). Kyoto Protocol to the United Nations Framework Convention on Climate Change. Retrieved March 12, 2025, from https://unfccc.int
United Nations Framework Convention on Climate Change (UNFCCC). (2015). The Paris Agreement. Retrieved March 12, 2025, from https://unfccc.int
United Nations Global Compact. (2004). Who cares wins. Retrieved March 12, 2025, from https://www.unglobalcompact.org
United Nations World Commission on Environment and Development (UNWCED). (1987). Our common future. Oxford University Press.
Wernerfelt, B. (1984). A resource-based view of the firm. Strategic Management Journal, 5(2), 171–180. https://doi.org/10.1002/smj.4250050207
White House. (2021). American clean energy plan. Retrieved March 12, 2025, from https://www.whitehouse.gov
Williams, A., Kennedy, S., Philipp, F., & Whiteman, G. (2017). Systems thinking: A review of sustainability management research. Journal of Cleaner Production, 148, 866–881. https://doi.org/10.1016/j.jclepro.2017.02.002
Yin, R. K. (2018). Case study research and applications: Design and methods (6th ed.). Thousand Oaks, CA: Sage Publications.
Yeung, H. W. C., & Liu, W. (2008). Globalizing China: The rise of mainland firms in the global economy. Eurasian Geography and Economics, 49(1), 57–86.
Zeller, C. (2004). North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas. Economic Geography, 80(1), 83-111.
Zollo, M., & Winter, S. G. (2002). Deliberate learning and the evolution of dynamic capabilities. Organization Science, 13(3), 339–351. https://doi.org/10.1287/orsc.13.3.339.2780
台灣趨勢研究（2024）。《 2024 製藥與藥品製造產業報告》。上網日期：2025年 1 月25日，檢自：https://www.twtrend.com/trend-detail/manufa
沈柏延（2022）。從動態能力的觀點探討企業的數位轉型。未出版之博士論文，國立政治大學，科技管理與智慧財產研究所，台北市。
林凱晴（2024）。以核心能耐觀點探討本土與在台外商藥廠之智慧資本。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。
生物技術醫療政策研究中心（2024）。《 2023 生醫上市櫃營收前 20 大暨各領域營收表現》。上網日期：2025年1月24日，檢自：https://ibmi.taiwan-healthcare.org/zh/news_detail.php?REFDOCID=0s731pmanz0o43x7&REFDOCTYPID=0qm3a0y0465xgddh
蘇志騰（2021）。以動態能耐觀點探討台灣鋰電池模組廠商轉型之個案研究－以S公司為例。未出版之碩士論文，國立政治大學，科技管理與智慧財產研究所，台北市。
行政院環保署（2022）。《氣候變遷因應法》。上網日期：2025年4月1日，檢自：https://www.epa.gov.tw
經濟部產業發展署（2024）。《 2024 生技產業白皮書》。台北市：中華民國經濟部。
鍾宜玲（2011）。跨國企業在台灣實行企業社會責任之探討——以醫藥產業為例。未出版之碩士論文，國立政治大學，台北市。 |
| 描述: | 碩士
國立政治大學
科技管理與智慧財產研究所
112364122 |
| 資料來源: | http://thesis.lib.nccu.edu.tw/record/#G0112364122 |
| 資料類型: | thesis |
| 顯示於類別: | [科技管理與智慧財產研究所] 學位論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 412201.pdf | | 6384Kb | Adobe PDF | 0 | 檢視/開啟 |
|
在政大典藏中所有的資料項目都受到原著作權保護.
|
